Abstract:Acute myocardial infarction (AMI) is the most common complications and risky adverse cardiovascular events in patients with chronic obstructive pulmonary disease (COPD), and both diseases share common risk factors and pathophysiological mechanisms. In recent years, it has been shown that the risk of AMI is significantly increased in patients with COPD. The standardized treatment of COPD can reduce the risk of AMI. Meanwhile, the medications for secondary prevention after AMI have been associated with reduced risk of acute exacerbation of COPD or mortality in patients with COPD. The research findings related to AMI complicated with COPD from home and abroad were summarized in this review from the aspects of common risk factors, pathophysiological mechanisms, risk assessment and treatment of medication, in order to provide a reference for the integrated multidisciplinary management and effective treatment for these patients.